Literature DB >> 10411545

Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.

K Kuzushima1, S Nakamura, T Nakamura, Y Yamamura, N Yokoyama, M Fujita, T Kiyono, T Tsurumi.   

Abstract

Gastric adenocarcinomas carrying Epstein-Barr virus (EBV) are known to be accompanied by massive lymphocyte infiltration. To characterize the tumor-infiltrating lymphocytes (TILs), we isolated and cultured such cells from a surgically resected EBV-associated gastric carcinoma. They were found to be positive for CD3, CD8, T-cell receptor beta chain, and cytotoxic molecules. The isolated TILs consisted of human leukocyte antigen (HLA) class I-restricted CD8(+) cytotoxic T lymphocytes (CTLs), which killed autologous EBV-transformed cells (but not phytohemagglutinin blast cells) and recognized HLA-A24 as restriction molecules. However, the TILs did not recognize known EBV antigenic peptides presented by HLA-A24 molecules, nor HLA-A24(+) fibroblasts infected with vaccinia recombinant virus expressing each of the EBV latent proteins. EBV(+) gastric carcinomas do not express conventional target proteins of EBV-specific CTLs, and the data suggest that some cellular proteins may be involved in the strong T-cell response to EBV-associated gastric carcinoma. In addition, our data suggest that class I-restricted, antigen-specific CD8(+) CTLs are specifically expanded within EBV(+) gastric carcinoma tissue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411545      PMCID: PMC408473          DOI: 10.1172/JCI6062

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.

Authors:  N Kienzle; T B Sculley; L Poulsen; M Buck; S Cross; N Raab-Traub; R Khanna
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

2.  Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.

Authors:  K Sakai; M Takiguchi; S Mori; O Kobori; Y Morioka; H Inoko; M Sekiguchi; K Kano
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

3.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

4.  Detection of Epstein-Barr virus by polymerase chain reaction.

Authors:  A Telenti; W F Marshall; T F Smith
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

5.  Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma.

Authors:  K Oda; J Tamaru; T Takenouchi; A Mikata; M Nunomura; N Saitoh; H Sarashina; N Nakajima
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

6.  Epstein-Barr virus in gastric carcinoma.

Authors:  M Tokunaga; C E Land; Y Uemura; T Tokudome; S Tanaka; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma.

Authors:  D Shibata; M Tokunaga; Y Uemura; E Sato; S Tanaka; L M Weiss
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

8.  Gastric carcinoma with lymphoid stroma. Analysis using mucin histochemistry and immunohistochemistry.

Authors:  N Lertprasertsuke; Y Tsutsumi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Epstein-Barr virus-associated gastric adenocarcinoma.

Authors:  D Shibata; L M Weiss
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

10.  Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus.

Authors:  J Lindenmann; P A Klein
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

Review 2.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

3.  Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy.

Authors:  J Biggerstaff; B Weidow; A Amirkhosravi; J L Francis
Journal:  BMC Immunol       Date:  2006-07-21       Impact factor: 3.615

4.  Correlation Between Infection Status of Epstein-Barr Virus and 18F-Fluorodeoxyglucose Uptake in Patients with Advanced Gastric Cancer.

Authors:  Sae Jung Na; Hye Lim Park; Joo Hyun O; Sung Yong Lee; Kyo Young Song; Sung Hoon Kim
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

5.  Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.

Authors:  Anna Maria Chiaravalli; Maddalena Feltri; Valentina Bertolini; Elena Bagnoli; Daniela Furlan; Roberta Cerutti; Raffaele Novario; Carlo Capella
Journal:  Virchows Arch       Date:  2005-10-27       Impact factor: 4.064

6.  Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.

Authors:  M Constanza Camargo; Woo-Ho Kim; Anna Maria Chiaravalli; Kyoung-Mee Kim; Alejandro H Corvalan; Keitaro Matsuo; Jun Yu; Joseph J Y Sung; Roberto Herrera-Goepfert; Fernando Meneses-Gonzalez; Yuko Kijima; Shoji Natsugoe; Linda M Liao; Jolanta Lissowska; Sung Kim; Nan Hu; Carlos A Gonzalez; Yashushi Yatabe; Chihaya Koriyama; Stephen M Hewitt; Suminori Akiba; Margaret L Gulley; Philip R Taylor; Charles S Rabkin
Journal:  Gut       Date:  2013-04-12       Impact factor: 23.059

7.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.

Authors:  Hiroshi Uozaki; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma.

Authors:  Byung-Hoon Min; Chung Hyun Tae; Soo Min Ahn; So Young Kang; Sook-Young Woo; Seonwoo Kim; Kyoung-Mee Kim
Journal:  Gastric Cancer       Date:  2015-08-12       Impact factor: 7.370

9.  Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation.

Authors:  Q N Vo; J Geradts; M L Gulley; D A Boudreau; J C Bravo; B G Schneider
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

10.  Pathology of epstein-barr virus-associated gastric carcinoma and its relationship to prognosis.

Authors:  Hye-Jong Song; Kyoung-Mee Kim
Journal:  Gut Liver       Date:  2011-06-24       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.